Unlocking the potential of ultra-low frequency variant identification for cancer research

Unlocking the potential of ultra-low frequency variant identification for cancer research

The discovery and validation of biomarkers in cancer research has become increasingly important for understanding disease mechanisms, identifying new therapeutic targets, and developing personalized treatment strategies.

This webinar focuses on the use of library preparation and hybrid capture solutions in biomarker discovery for cancer profiling by NGS. In this webinar, you will learn about:

  • High library complexity from low-quality and complex sample types
  • Predesigned and custom approaches for hybridization capture
  • Complete sample preparation workflows for minimal residual disease (MRD) research

Published on: September 26, 2023